Review 12292 national registry of M20 l山properly Lau )Ant 1 hear product.SaA trial 74 n.G P.Ch H. Haynes RB.Cotoi C.Hol NY:Me B H恤2014 R.Hen y D.Moons KGM.U nzi R.B 10e643-万 k S.Akl E 102 Lohr KN.Comp 2013: 103 or 104 nt and ace 017 105 Antes G.Chal ch KF. gldareportngofdinialthlncthial 1 307 d ed 10 Ag 21.20 RA akcing the (US 109 84 Miles AM,Bentley P. 110 Vandvik PO,Brandt L,A 85 Miles 111s evidence-based medicine (200524 113 ifed an 114 Hozo I.D BM2013532452 ides to th 115 ry 16,2017 http://d rg/10.1016/50140-6736163H592- 9Review www.thelancet.com Published online February 16, 2017 http://dx.doi.org/10.1016/S0140-6736(16)31592-6 9 67 Chalmers I, Glasziou P, Godlee F. All trials must be registered and the results published. BMJ 2013; 346: f105. 68 McGauran N, Wieseler B, Kreis J, Schuler YB, Kolsch H, Kaiser T. Reporting bias in medical research—a narrative review. Trials 2010; 11: 37. 69 Simes RJ. Publication bias: the case for an international registry of clinical trials. J Clin Oncol 1986; 4: 1529–41. 70 Goldacre B. Make journals report clinical trials properly. Nature 2016; 530: 7. 71 Sackett DL. Why randomized controlled trials fail but needn’t: 1. failure to gain “coal-face” commitment and to use the uncertainty principle. CMAJ 2000; 162: 1311–14. 72 Djulbegovic B, Lyman GH, Ruckdeschel J. Why evidence-based oncology? Evidence-based Oncology 2000; 1: 2–5. 73 MEDLINE Fact Sheet. 2016. https://www.nlm.nih.gov/pubs/ factsheets/medline.html (accessed April 20, 2016). 74 Bastian H, Glasziou P, Chalmers I. Seventy-fi ve trials and eleven systematic reviews a day: how will we ever keep up? PLoS Med 2010; 7: e1000326. 75 Haynes RB, Cotoi C, Holland J, et al. Second-order peer review of the medical literature for clinical practitioners. JAMA 2006; 295: 1801–08. 76 Vincent S, Djulbegovic B. Oncology treatment recommendations can be supported only by 1-2% of published high-quality evidence. Cancer Treat Rev 2005; 314: 319–22. 77 Kwag KH, González-Lorenzo M, Banzi R, Bonovas S, Moja L. Providing doctors with high-quality information: an updated evaluation of web-based point-of-care information summaries. J Med Internet Res 2016; 18: e15. 78 Vandvik P, Brandt L, Alonso-Coello P, Treweek S, Akl E, Kristiansen A. Creating clinical practice guidelines we can trust, use, and share: a new era is imminent. Chest 2013; 144: 381–89. 79 Kristiansen A, Brandt L, Agoritsas T, et al. Applying new strategies for the national adaptation, updating, and dissemination of trustworthy guidelines: results from the Norwegian adaptation of the Antithrombotic Therapy and the Prevention of Thrombosis, 9th edn: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2014; 146: 735–61. 80 Appelt KC, Milch KF, Handgraaf MJJ, Weber EU. The decision making individual diff erences inventory and guidelines for the study of individual diff erences in judgment and decision-making research. Judgm Decis Mak 2011; 6: 252–62. 81 Hastie R, Dawes RM. Rational choice in an uncertain world. 2nd edn. Los Angeles, CA: Sage Publications, Inc., 2010. 82 A to Z Inventory of Decision Aids. https://decisionaid.ohri.ca/ azinvent.php. (accessed Aug 21, 2016). 83 Hargraves I, LeBlanc A, Shah ND, Montori VM. Shared decision making: the need for patient-clinician conversation, not just information. Health Aff (Millwood) 2016; 35: 627–29. 84 Miles AM, Bentley P, Polychronis A, Grey J, Price N. Advancing the evidence-based healthcare debate. J Eval Clin Pract 1999; 5: 97–101. 85 Miles A, Bentey P, Polychronis A, Grey J. Evidence-based medicine: why all the fuss? This is why. J Eval Clin Pract 1997; 3: 83–86. 86 Miles A, Grey J. New perspectives in the evidence-based healthcare debate. J Eval Clin Pract 2000; 6: 77–84. 87 Timmermans S, Mauck A. The promises and pitfalls of evidence-based medicine. Health Aff (Millwood) 2005; 24: 18–28. 88 Greenhalgh T, Howick J, Maskrey N. Evidence based medicine: a movement in crisis? 2014; 348: g3725. 89 Miles A, Asbridge JE, Caballero F. Towards a person-centered medical education: challenges and imperatives. Educ Med 2015; 16: 25–33. 90 McCartney M, Treadwell J, Maskrey N, Lehman R. Making evidence based medicine work for individual patients. BMJ 2016; 353: i2452. 91 Guyatt GH, Haynes RB, Jaeschke RZ, et al. Users’ guides to the medical literature: XXV. Evidence-based medicine: principles for applying the Users’ Guides to patient care. Evidence-Based Medicine Working Group. JAMA 2000; 284: 1290–96. 92 Guyatt GH, Keller JL, Jaeschke R, Rosenbloom D, Adachi JD, Newhouse MT. The n-of-1 randomized controlled trial: clinical usefulness. Our three-year experience. Ann Intern Med 1990; 112: 293–99. 93 Sun X, Briel M, Walter SD, Guyatt GH. Is a subgroup eff ect believable? Updating criteria to evaluate the credibility of subgroup analyses. BMJ 2010; 340: c117. 94 Lau J, Antman EM, Jimenez-Silva J, Mosteller F, Chalmers TC. Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med; 327: 248–54. 95 Ioannidis JPA. Evidence-based medicine has been hijacked: a report to David Sackett. J Clin Epidemiol 2016; 73: 82–86. 96 Michaels D. Doubt is their product. Sci Am 2005; 292: 96–101. 97 Chan AW. Bias, spin, and misreporting: time for full access to trial protocols and results. PLoS Med 2008; 5: e230. 98 Mann H, Djulbegovic B. Comparator bias: why comparisons must address genuine uncertainties. J R Soc Med 2013; 106: 30–33. 99 Carrasco-Labra A, Montori VM, Ioannidis JPA, et al. Misleading presentations of clinical trial results. In: Guyatt GRD, Meade M, Cook D, eds. Users’ guides to the medical literature: a manual for evidence-based clinical practice. 3rd edn. New York, NY: McGraw￾Hill, 2014. 100 Moynihan R, Henry D, Moons KGM. Using evidence to combat overdiagnosis and overtreatment: evaluating treatments, tests, and disease defi nitions in the time of too much. PLoS Med 2014; 11: e1001655. 101 Pirolli P, Card S. Information foraging. Psychol Rev 1999; 106: 643–75. 102 Lohr KN. Comparative eff ectiveness research methods: symposium overview and summary. Med Care 2010; 48 (6 suppl): S3–S6. 103 Berenson RA, Pronovost PJ, Krumholz HM. Achieving the potential of health care performance measures. 2013. http://www.nejm.org/ doi/full/10.1056/NEJMp1312287 (accessed Aug 21, 2016). 104 Simera I, Moher D, Hirst A, Hoey J, Schulz KF, Altman DG. Transparent and accurate reporting increases reliability, utility, and impact of your research: reporting guidelines and the EQUATOR Network. BMC Med 2010; 8: 24. 105 Antes G, Chalmers I. Under-reporting of clinical trials is unethical. Lancet 2003; 361: 978–79. 106 Elshau AG, Watt AM, Mundy L, Willis CD. Over 150 potentially low-value health care practices: an Australian study. Med J Aust 2012; 197: 556–60. 107 Schünemann HJ, Moja L. Reviews: Rapid! Rapid! Rapid!…and systematic. Syst Rev 2015; 4: 1–3. 108 Paynter RA, Bañez LL, Berliner E, et al. EPC methods: an exploration of the use of text-mining software in systematic reviews. Research White Paper. Rockville, MD: Agency for Healthcare Research and Quality (US), 2016. 109 Guyatt G, Vandvik PO. Creating clinical practice guidelines: problems and solutions. Chest 2013; 144: 365–67. 110 Vandvik PO, Brandt L, Alonso-Coello P, et al. Creating clinical practice guidelines we can trust, use, and share: a new era is imminent. Chest 2013; 144: 381–89. 111 Sim I. Two ways of knowing: big data and evidence-based medicine. Ann Intern Med 2016; 164: 562–63. 112 IOM (Institute of Medicine). Best care at lower cost: The path to continuously learning health care in America. Washington, DC: The National Academies Press, 2013. 113 Eddy DM. Evidence-based medicine: a unifi ed approach. Health Aff (Millwood) 2005; 24: 9–17. 114 Hozo I, Djulbegovic B, Luan S, Tsalatsanis A, Gigerenzer G. Towards theory integration: threshold model as a link between signal detection theory, fast-and-frugal trees and evidence accumulation theory. J Eval Clin Pract 2015; published online Dec 18. DOI:10.1111/jep.12490. 115 Karanicolas PJ, Kunz R, Guyatt GH. Point: evidence-based medicine has a sound scientifi c base. Chest 2008; 133: 1067–71